ArticleEndocrine pathology2024

SATB2 is an Emergent Biomarker of Anaplastic Thyroid Carcinoma: A Series with Comprehensive Biomarker and Molecular Studies.

Dingani Nkosi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.